ANDA 83613, held by Ivax Sub Teva Pharms. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 83613 (Promethazine Hydrochloride), held by Ivax Sub Teva Pharms, was first approved by FDA on Sep 21, 1973, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 21, 1973 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride50MG ยท tablet;oral | Promethazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters